News | October 15, 2021
Shilpa Medicare raises over Rs. 297 crore through preferential allotment
Equity raise to finance growth and investments in the biological space
Equity raise to finance growth and investments in the biological space
The issue will consist of the issuance of fresh equity shares worth up to Rs 331.60 crore and an offer for sale (OFS) of Rs 500 crore by promoters and existing shareholders
The listings aim to address global health priorities, identifying the medicines that provide the greatest benefits, and which should be available and affordable for all
CuraTeQ Biologics is on track for filing a second oncology biosimilar
It becomes the first ophthalmology biosimilar to gain FDA approval in the United States
_256_384.jpg)
CLSA, a capital market and investment group organised an Investors’ Forum where five Indian pharma companies participated. Excerpts from the report
Sandoz is committed to building on its leading generic and biosimilar oncology portfolio to further expand patient access while contributing to the sustainability of healthcare systems
The agreement is to develop, manufacture and commercialise biosimilars for the global market.
FDA approval of the first interchangeable biosimilar insulin will drive the US Insulin biosimilar market, says Kuick Research.
He will be responsible for the company's overall strategy and provide the necessary direction and dynamic leadership to R&D, manufacturing, business development, and commercial operations
Subscribe To Our Newsletter & Stay Updated
